cyc 202 has been researched along with dinoprostone in 2 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
979 | 7 | 393 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | cyc 202 (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Deng, W; Kang, T; Liu, L; Shi, D; Wang, J; Xiao, X; Xie, X | 1 |
2 other study(ies) available for cyc 202 and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling.
Topics: Acetylation; Antioxidants; Blotting, Western; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation, Enzymologic; Humans; Neovascularization, Physiologic; NF-kappa B; Oligonucleotide Probes; p300-CBP Transcription Factors; Promoter Regions, Genetic; Protein Binding; Purines; Quercetin; Reverse Transcriptase Polymerase Chain Reaction; Roscovitine; Signal Transduction | 2011 |